MedTrace Logo

Body Composition and Very-Low-Density-Lipoprotein-Triglycerides (VLDL-TG) Kinetics

NCT00646698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2008-03-28

No results posted yet for this study

Summary

Context: Upper body obese (UBO) subjects are more likely to develop cardiovascular disease (CVD) than lower body obese (LBO) or lean. This may in part be caused by greater hepatic secretion of very-low-density-lipoprotein-triglycerides (VLDL-TG).

Objective: To assess the impact of body composition and insulin sensitivity on basal VLDL-TG turnover in women.

Conditions

Sponsors & Collaborators

  • The Danish Medical Research Council

    collaborator OTHER

  • The Novo Nordic Foundation

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Lars C Gormsen, MD PhD · Aarhus University Hospital, Department M

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2007-02-28
Completion
2007-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00646698 on ClinicalTrials.gov